These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29358291)

  • 21. Pharmacokinetics of oral fludrocortisone in septic shock.
    Polito A; Hamitouche N; Ribot M; Polito A; Laviolle B; Bellissant E; Annane D; Alvarez JC
    Br J Clin Pharmacol; 2016 Dec; 82(6):1509-1516. PubMed ID: 27416887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of Piperacillin in Critically Ill Australian Indigenous Patients with Severe Sepsis.
    Tsai D; Stewart P; Goud R; Gourley S; Hewagama S; Krishnaswamy S; Wallis SC; Lipman J; Roberts JA
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7402-7406. PubMed ID: 27736759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of tigecycline in critically ill patients with serious nosocomial intra-abdominal infections.
    Maseda E; Denis SE; Riquelme A; Gilsanz F
    Rev Esp Quimioter; 2013 Mar; 26(1):56-63. PubMed ID: 23546465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the ratio of the estimated area under the concentration-time curve to minimum inhibitory concentration (estimated AUIC) as a predictor of the outcome for tigecycline treatment for pneumonia due to multidrug-resistant bacteria in an intensive care unit.
    Xu Y; Jin L; Liu N; Luo X; Dong D; Tang J; Wang Y; You Y; Liu Y; Chen M; Yu Z; Hao Y; Gu Q
    Int J Infect Dis; 2019 May; 82():79-85. PubMed ID: 30878630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population Pharmacokinetics and Pharmacodynamics Modeling To Optimize Dosage Regimens of Sulbactam in Critically Ill Patients with Severe Sepsis Caused by Acinetobacter baumannii.
    Jaruratanasirikul S; Wongpoowarak W; Wattanavijitkul T; Sukarnjanaset W; Samaeng M; Nawakitrangsan M; Ingviya N
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7236-7244. PubMed ID: 27671056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis.
    Buerger C; Plock N; Dehghanyar P; Joukhadar C; Kloft C
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2455-63. PubMed ID: 16801426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
    Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic and Pharmacodynamic Evaluation of Doripenem in Critically Ill Trauma Patients with Sepsis.
    Rahbar AJ; Lodise TP; Abraham P; Lockwood A; Pai MP; Patka J; Rabinovich M; Curzio K; Chester K; Williams B; Morse B; Chaar M; Huang V; Salomone J
    Surg Infect (Larchmt); 2016 Dec; 17(6):675-682. PubMed ID: 27841954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Personalised antibiotic therapy in a surgical intensive care unit overview of current knowledge and the results of an observational kinetic study].
    Kaška M; Martinková J; Havel E; Kočí J; Fousková A; Solichová D; Kujovská L; Selke-Krulichová I; Práznovec I; Salavec V
    Rozhl Chir; 2014 Sep; 93(9):456-62. PubMed ID: 25301344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsis.
    Hartman SJF; Boeddha NP; Ekinci E; Koch BCP; Donders R; Hazelzet JA; Driessen GJ; de Wildt SN
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1255-1260. PubMed ID: 30968258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of meropenem in critically ill patients with severe infections.
    Binder L; Schwörer H; Hoppe S; Streit F; Neumann S; Beckmann A; Wachter R; Oellerich M; Walson PD
    Ther Drug Monit; 2013 Feb; 35(1):63-70. PubMed ID: 23318279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration.
    Jamal JA; Roberts DM; Udy AA; Mat-Nor MB; Mohamad-Nor FS; Wallis SC; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2015 Jul; 46(1):39-44. PubMed ID: 25881872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics of tigecycline in patients with complicated intra-abdominal or skin and skin structure infections.
    Van Wart SA; Owen JS; Ludwig EA; Meagher AK; Korth-Bradley JM; Cirincione BB
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3701-7. PubMed ID: 16940069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.
    Radke C; Horn D; Lanckohr C; Ellger B; Meyer M; Eissing T; Hempel G
    Clin Pharmacokinet; 2017 Jul; 56(7):759-779. PubMed ID: 28039606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
    Udy AA; Covajes C; Taccone FS; Jacobs F; Vincent JL; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2013 Jun; 41(6):564-8. PubMed ID: 23473944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adequate anti-infective treatment : Importance of individual dosing and application].
    Brinkmann A; Röhr AC; Köberer A; Fuchs T; Krüger WA; König C; Richter D; Weigand MA; Frey OR
    Anaesthesist; 2018 Jun; 67(6):461-476. PubMed ID: 29766208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality.
    Garnacho-Montero J; Gutiérrez-Pizarraya A; Escoresca-Ortega A; Fernández-Delgado E; López-Sánchez JM
    Crit Care; 2015 Aug; 19(1):302. PubMed ID: 26307060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma and interstitial fluid population pharmacokinetics of vancomycin in critically ill patients with sepsis.
    Abraham J; Sinnollareddy MG; Roberts MS; Williams P; Peake SL; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2019 Feb; 53(2):137-142. PubMed ID: 30296581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tigecycline for the treatment of patients with severe sepsis or septic shock: a drug use evaluation in a surgical intensive care unit.
    Swoboda S; Ober M; Hainer C; Lichtenstern C; Seiler C; Wendt C; Hoppe-Tichy T; Büchler M; Weigand MA
    J Antimicrob Chemother; 2008 Mar; 61(3):729-33. PubMed ID: 18222953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic parameters over time during sepsis and the association of target attainment and outcomes in critically ill children and young adults receiving ceftriaxone.
    Tang Girdwood S; Tang P; Fenchel M; Dong M; Stoneman E; Jones R; Ostermeier A; Curry C; Forton M; Hail T; Mullaney R; Diseroad E; Punt N; Kaplan J; Vinks AA
    Pharmacotherapy; 2023 Jul; 43(7):609-621. PubMed ID: 36727212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.